SLC2A4 and polycystic ovary syndrome: Although a study by Ciaraldi and colleagues found no difference in GLUT4 levels between PCOS women and control subjects [123], there is a consensus that the regulation of GLUT4 expression is a critical molecular endpoint for insulin resistance in the adipose tissue of PCOS patients.